gavi.org
GOVERNANCE COMMITTEE CHAIR REPORT
BOARD MEETING
Sarah Goulding
7 -8 December 2022, Geneva, Switzerland
Routine (Recurring) Work
? Board and Committee nominations, including Committee Leadership
? Recruitment of Unaffiliated Board Members (GC Subcommittee)
? Monitoring of application of Guiding Principles on Gender for Board and Committee
nominations
? Monitoring of Governance Risk Matrix
2 Board Meeting, 7 -8 December 2022

gavi.org
INVESTMENT COMMITTEE
CHAIR REPORT
BOARD MEETING
Afsaneh Beschloss
7 -8 December 2022, Geneva, Switzerland
Easy Monetary Policy Inflated Asset Prices
2 Board Meeting, 7 -8 December 2022
1Q
2022
2Q
2022
3Q
2022
4Q
2022
1Q
2023
Bloomberg Data Monthly as of 09 Nov 2022
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
0
5
10
15
20
25
30
35
40
Balance Sheet (USD Trillions)
Central Bank Balance Sheet Versus S&P 500
Fed ECB China Japan S&P 500

gavi.org
IFFIM CHAIR REPORT
BOARD MEETING
Kenneth Lay
7 -8 December 2022, Geneva, Switzerland
IFFIm contribution to Gavi?s funding requirements
? In the period 2016 -2020 (Gavi 4.0), IFFIm contributed US$ 872 million to Gavi
? In the 2021 -2025 period (Gavi 5.0), IFFIm has the capacity to provide US$ 3.4 billion
? US$ 2.5 billion for core funding
? US$ 975 million for COVAX AMC
? Disbursements for Gavi 5.0 as of end August 2022 are US$ 1.2 billion
? US$ 957 million for core funding
? US$ 209 million for COVAX AMC
? IFFIm has provided 17 % of Gavi resources to countries since 2006
2 Board Meeting, 7 -8 December 2022

PPC Meeting, 31 October - 1 November 2022
Discussion, Information and Guidance Items
? CEO Report
? COVAX ? Key Strategic Issues
2 Board Meeting, 7 -8 December 2022
PPC Meeting, 31 October - 1 November 2022
Recommendations to the Board
? Human papillomavirus (HPV) Vaccine Programme ( Agenda Item 7 )
? Gavi?s role in support to Regional and African Vaccine Manufacturing ( Agenda Item 8 )
? Gavi?s role in a future COVID -19 Vaccine Programme ( Agenda Item 10 )
? Funding Policy Review ( Agenda Item 11 )
? Gavi Support for Inactivated Poliovirus Vaccine ( Consent Agenda )
3 Board Meeting, 7 -8 December 2022

This document aims to address: 1. Introduce real-time monitoring approaches and how RTM can strengthen vaccination campaigns and routine immunization programmes; 2. Provide guidance to decision-makers and planners on the key considerations enabling implementation of real time approaches and digital solutions in order to strengthen vaccination campaigns and routine immunization programmes, thereby enhancing immunization service delivery; 3. Elaborate on implementation aspects related to realtime monitoring technologies.

This country technical brief presents three use cases of Real Time Monitoring (RTM) approaches used in Rwanda for 1) COVID19 surveillance 2) Vaccination Delivery and Monitoring and 3) COVID19 case management. Good practices and lessons learned by Rwanda are also highlighted in the brief.